OTC Markets OTCPK - Delayed Quote USD
SIMPLY SOLVENTLESS CONCENTRATES (SSLCF)
0.3200
0.0000
(0.00%)
At close: May 6 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,460.6880
6,191.6460
2,799.3670
1,216.2580
Cost of Revenue
6,175.5860
2,694.3670
2,760.9400
1,724.9970
Gross Profit
5,285.1020
3,497.2790
38.4270
-508.7390
Operating Expense
3,159.6000
1,481.1880
1,407.7680
1,814.6910
Operating Income
2,125.5020
2,016.0910
-1,369.3410
-2,323.4300
Net Non Operating Interest Income Expense
-205.8830
-337.3460
-314.3810
-3.0710
Other Income Expense
-772.0770
-637.7010
-0.0770
--
Pretax Income
1,147.5420
1,041.0440
-1,683.7990
-2,326.5010
Net Income Common Stockholders
1,146.8140
1,040.3160
-1,683.7990
-2,326.5010
Diluted NI Available to Com Stockholders
1,146.8140
1,040.3160
-1,683.7990
-2,326.5010
Basic EPS
0.01
0.03
-0.03
-0.05
Diluted EPS
0.01
0.02
-0.03
-0.05
Basic Average Shares
77,736.5400
38,691.3020
50,475.1890
50,475.1890
Diluted Average Shares
77,736.5400
41,692.5930
50,475.1890
50,475.1890
Total Operating Income as Reported
1,899.4260
2,015.3630
-1,369.3410
-2,323.4300
Rent Expense Supplemental
--
0
3.0120
3.6700
Total Expenses
9,335.1860
4,175.5550
4,168.7080
3,539.6880
Net Income from Continuing & Discontinued Operation
1,146.8140
1,040.3160
-1,683.7990
-2,326.5010
Normalized Income
2,182.9300
1,422.9366
-1,683.7220
-2,326.5010
Interest Expense
--
--
314.3810
3.0710
Net Interest Income
-205.8830
-337.3460
-314.3810
-3.0710
EBIT
2,125.5020
2,016.0910
-1,369.3410
-2,323.4300
EBITDA
2,192.2820
2,064.2980
-1,084.9340
-2,245.6750
Reconciled Cost of Revenue
6,179.3410
2,694.3680
2,706.3870
1,724.9970
Reconciled Depreciation
63.0250
48.2060
284.4070
77.7550
Net Income from Continuing Operation Net Minority Interest
1,146.8140
1,040.3160
-1,683.7990
-2,326.5010
Total Unusual Items Excluding Goodwill
-1,218.9600
-637.7010
-0.0770
--
Total Unusual Items
-1,218.9600
-637.7010
-0.0770
--
Normalized EBITDA
3,411.2420
2,701.9990
-1,084.8570
-2,245.6750
Tax Rate for Calcs
0.0002
0.0004
0
0
Tax Effect of Unusual Items
-182.8440
-255.0804
0
0
12/31/2021 - 7/22/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CANB.V CanadaBis Capital Inc.
0.0500
0.00%
BIOGY BioGaia AB (publ)
10.81
0.00%
MJ.CN Maven Brands Inc.
0.0200
0.00%
BGLAF BioGaia AB (publ)
9.58
0.00%
NMV.F Captor Capital Corp.
0.2940
0.00%
CNADF CanadaBis Capital Inc.
0.0625
0.00%
EQL.ST EQL Pharma AB
76.60
-3.04%
RAMM.CN RAMM Pharma Corp.
0.0100
0.00%
MILFF 1CM Inc.
0.1942
0.00%
XTXXF Adastra Holdings Ltd.
0.0378
0.00%